Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
1650-G allogeneic cellular vaccine
/
University of Kentucky
Welcome,
Profile
Billing
Logout
9 Diseases
0 Trials
0 Trials
1 News
||||||||||
1650-G allogeneic cellular vaccine
/
University of Kentucky
New P1 trial:
Lung Cancer Vaccine Plus Oral Dietary Supplement
(clinicaltrials.gov) - Apr 9, 2013
P1
, N=5, Completed,
Sponsor: Edward Hirschowitz